Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Middle East Pharmaceutical Industries Company SJSC
Cash from Operating Activities
Middle East Pharmaceutical Industries Company SJSC
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
|
Cash from Operating Activities
ď·Ľ92.7m
|
CAGR 3-Years
28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC
SAU:2070
|
Cash from Operating Activities
-ď·Ľ159.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-5%
|
|
|
J
|
Jamjoom Pharmaceuticals Factory Company SJSC
SAU:4015
|
Cash from Operating Activities
ď·Ľ263.3m
|
CAGR 3-Years
5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Middle East Pharmaceutical Industries Company SJSC
Glance View
Middle East Pharmaceutical Industries Company SJSC is a SA-based company operating in Pharmaceuticals industry. The company is headquartered in Riyadh, Riyadh and currently employs 335 full-time employees. The company went IPO on 2024-02-27. Middle East Pharmaceutical Industries Company SJSC is a Saudi Arabia-based pharmaceutical company. The firm develops, manufactures, markets, and distributes a wide range of generic medicines and pharmaceuticals. The Company’s activity is the manufacture of disinfectants and sterilizers for medical devices and products, the manufacture of disinfectants and sterilizers for non-medical use, the manufacture of cosmetics, and the manufacture of pharmaceutical preparations for human use.
See Also
What is Middle East Pharmaceutical Industries Company SJSC's Cash from Operating Activities?
Cash from Operating Activities
92.7m
SAR
Based on the financial report for Dec 31, 2023, Middle East Pharmaceutical Industries Company SJSC's Cash from Operating Activities amounts to 92.7m SAR.
What is Middle East Pharmaceutical Industries Company SJSC's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
28%
Over the last year, the Cash from Operating Activities growth was 35%. The average annual Cash from Operating Activities growth rates for Middle East Pharmaceutical Industries Company SJSC have been 28% over the past three years .
You don't have any saved screeners yet